What is a brain shock? A brain shock is an electric shock sensation and feeling in the brain. It is usually a reaction to when you stop taking antidepressants. It is a common withdrawal symptom that happens.
What is a brain shock? iStock-photo credit: peterschreiber.media
Some of those symptoms are:
• Buzzing sounds
• Dizziness
• Disorientation
• Vertigo
• Confused state.
There was a study that was done in over 3000 people that taking these 9 antidepressants were linked to brain zaps. Those were venlafaxine, Zoloft, bupropion, duloxetine, paroxetine, venlafaxine, desvenlafaxine, etc. Some people also get brain zaps after they stop taking ecstasy, Xanax and Adderall, etc.
Some withdrawal symptoms can last up to a couple of months but typically on average it’s a couple of days. The best way to minimize brain zaps or brain shocks is to gradually discontinue yourself off the SSRI, also known as selective serotonin reuptake inhibitors.
Some of the best things you can do to manage your brain zaps is trying to move and exercise. Also trying to get more fresh air as well as get enough sleep in 7 to 9 hours per day.
The Bottom Line is brain shocks, which is an electric shock sensation feeling in the brain when you stop taking antidepressants or SSRI which is called selective serotonin reuptake inhibitors.
If you have any interest in trying any of our Ethical Supplement products to help you heighten your immune system or assist you with your fitness, weight loss or health goals. You can get a discount below at this link.
https://ethicalinc.com/product/appetite-suppressant/
About Author- Obi Obadike
About – Ethical Inc
https://about.sharecare.com/press-releases/sharecare-names-top-10-fittest-cities-america/
References
1) Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4. PMID: 30292574.
2) Ionescu DF, Rosenbaum JF, Alpert JE. Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues Clin Neurosci. 2015 Jun;17(2):111-26. doi: 10.31887/DCNS.2015.17.2/dionescu. PMID: 26246787; PMCID: PMC4518696.
3) Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr. 2016 Jun;39(3):76-83. doi: 10.18773/austprescr.2016.039. Epub 2016 Jun 1. PMID: 27346915; PMCID: PMC4919171.
4) Gautam S, Jain A, Gautam M, Vahia VN, Grover S. Clinical Practice Guidelines for the management of Depression. Indian J Psychiatry. 2017 Jan;59(Suppl 1):S34-S50. doi: 10.4103/0019-5545.196973. PMID: 28216784; PMCID: PMC5310101.
